Skip to content
healthcare.dev

VAQTA

NDC 0006-4831, hepatitis A vaccine, inactivated, injection, suspension, from Merck Sharp & Dohme LLC.

Product NDC
0006-4831
Status
Listed
Labeler
Merck Sharp & Dohme LLC
Dosage form
INJECTION, SUSPENSION
Route
INTRAMUSCULAR
Product type
VACCINE
Marketing category
BLA
Application
BLA103606
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/0006-4831 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • HEPATITIS A VIRUS STRAIN CR 326F ANTIGEN (FORMALDEHYDE INACTIVATED)25 [iU]/.5mL

Pharmacologic classes

Actively Acquired Immunity [PE]; Hepatitis A Vaccines [CS]; Inactivated Hepatitis A Virus Vaccine [EPC]; Vaccines, Inactivated [CS]

Package NDCNDC-11Package
0006-4831-410000648314110 VIAL, SINGLE-DOSE in 1 CARTON (0006-4831-41) / .5 mL in 1 VIAL, SINGLE-DOSE (0006-4831-01)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.

Use it

Look up 0006-4831 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/0006-4831 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 0006-4831. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.